Patents Issued in September 14, 2004
  • Patent number: 6790968
    Abstract: A microorganism having ability to produce FKI-0076 substance represented by the following formula [I] is cultured in a medium allowing for the accumulation of FKI-0076 substance in the culture liquid. The FKI-0076 substance from can then be isolated the cultured mass. Since the substance has the ability to enhance azole antifungal agents, it provides an action against various fungal infections such as deep-seated mycosis and other fungal infections in low concentration and within a short term. Consequently, the FKI-0076 is useful for reducing the frequency of appearance of resistant microorganisms. Further, usefulness for overcoming resistance is expected.
    Type: Grant
    Filed: October 24, 2002
    Date of Patent: September 14, 2004
    Assignee: The Kitasato Institute
    Inventors: Satoshi Omura, Hiroshi Tomoda, Rokuro Masuma, Masayoshi Arai
  • Patent number: 6790969
    Abstract: A process for regenerating a zeolite catalyst comprises thermal treatment of the catalyst at above 120° C. in the presence of a gas stream comprising hydrogen.
    Type: Grant
    Filed: March 4, 2003
    Date of Patent: September 14, 2004
    Assignee: BASF Aktiengesellschaft
    Inventors: Ulrich Müller, Joaquim Henrique Teles, Anne Wenzel, Wolfgang Harder, Peter Rudolf, Alwin Rehfinger, Peter Ba&bgr;ler, Norbert Rieber
  • Patent number: 6790970
    Abstract: The present invention provides a novel (meth)acrylic acid ester compound useful as a resin material for photosensitive compositions, which enables control of the molecular weight of a resin to be prepared. The novel (meth)acrylic acid ester compound is one represented by the following formula (I): wherein R1 and R2 each independently represent a hydrogen atom or a hydroxyl group; and R3 represents a hydrogen atom or a methyl group.
    Type: Grant
    Filed: March 25, 1999
    Date of Patent: September 14, 2004
    Assignee: Fuji Photo Film Co., Ltd.
    Inventors: Kenichiro Sato, Toshiaki Aoai
  • Patent number: 6790971
    Abstract: A 19-nor-steroid having a formula selected from the group consisting of wherein the A and B rings have a structure selected from the group consisting of having hormonal properties and their preparation and novel intermediates.
    Type: Grant
    Filed: May 17, 1995
    Date of Patent: September 14, 2004
    Assignee: Aventis Pharma S.A.
    Inventors: Andrè Claussner, Lucien Nedelec, Daniel Philibert, Patrick Van De Velde, François Nique, Jean-Georges Teutsch
  • Patent number: 6790972
    Abstract: The invention relates to new compounds having an element of group 12 and having a tridentate ligand, a process for their preparation and their use in particular as a polymerization catalyst.
    Type: Grant
    Filed: December 20, 2001
    Date of Patent: September 14, 2004
    Assignees: Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.), Centre National de la Recherche Scientifique (C.N.R.S.)
    Inventors: Hanh Nguyen Ngoc, Heinz Gornitzka, Blanca Martin-Vaca, Didier Bourissou, Guy Bertrand, Jean-Bernard Cazaux
  • Patent number: 6790973
    Abstract: The invention provides novel ruthenium complexes having an optically active diphosphine compound, which has asymmetry on carbon and is easy to synthesize, as the ligand and a process for preparing optically active alcoholic compounds using said complexes as the catalysts, wherein said process is the process for preparing optically active alcoholic compounds, which are excellent in terms of reactivity, enatioselectivity and the like in an asymmetric hydrogenation of carbonyl compounds compared with conventional ruthenium complex catalysts having an optically active diphosphine compound having the axial chirality or the asymmetry on carbon as the ligand.
    Type: Grant
    Filed: December 27, 2002
    Date of Patent: September 14, 2004
    Assignee: Kanto Kagaku Kabushiki Kaisha
    Inventors: Kunihiko Tsutsumi, Kunihiko Murata, Takeshi Ota, Takao Ikariya
  • Patent number: 6790974
    Abstract: A bis(aminostyryl)naphthalene compound represented by the general formula [I] or the like below. General Formula [I] (where R2 and R3 each denotes an unsubstituted aryl group; R1 and R4 each denotes an aryl group having a specific substituent such as methoxy group; and R5 and R6 each denotes a cyano group or the like.) A process for producing a bis(aminostyryl)naphthalene compound represented by the general formula [I] by condensation of, for example, 4-(N,N-diarylamino)benzaldehyde with diphosphonic ester or diphosphonium. The bis(aminostyryl)naphthalene compound emits intense yellow or red light. The process permits efficient production of the bis(aminostyryl)naphthalene compound.
    Type: Grant
    Filed: March 17, 2003
    Date of Patent: September 14, 2004
    Assignee: Sony Corporation
    Inventors: Mari Ichimura, Tadashi Ishibashi, Shinichiro Tamura
  • Patent number: 6790975
    Abstract: This invention is an aminostyrylanthracene compound represented by, for example, the following general formula [I]. This compound is produced by condensation from a corresponding aminobenzaldehyde and a phosphonic ester or phosphonium salt. [where, in the general formula [I] above, R2 represents an unsubstituted aryl group, R1 represents an aryl group which may have a variety of substituents, and R3 to R5 each represent a hydrogen atom, a cyano group, or a hydrocarbon group.
    Type: Grant
    Filed: March 19, 2002
    Date of Patent: September 14, 2004
    Assignee: Sony Corporation
    Inventors: Mari Ichimura, Tadashi Ishibashi, Shinichiro Tamura
  • Patent number: 6790976
    Abstract: The present invention relates to a process for producing tricarbonitriles corresponding to formula I wherein n is an integer from 2 to 11 by forming an intermediate in the presence of a strong base in a first stage from an aliphatic &agr;-&ohgr;-dinitrile corresponding to formula II wherein n is an integer from 3 to 12, and reacting the intermediate in a second stage to form a trinitrile corresponding to formula I by the addition of acrylonitrile.
    Type: Grant
    Filed: June 28, 2001
    Date of Patent: September 14, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Michael Schelhaas, Manfred Jautelat
  • Patent number: 6790977
    Abstract: A process for preparing 3,4-dihydroxybenzonitrile includes the steps of reacting a nitrile compound with an alkali metal halide, followed by treating with an acid.
    Type: Grant
    Filed: July 30, 2002
    Date of Patent: September 14, 2004
    Assignee: Sinon Corporation
    Inventors: Lung-Huang Kuo, Dei-She Ke, Chih-Da Lin, Shyh-Shyan Jwo, Wen-Hsin Chang
  • Patent number: 6790978
    Abstract: Compounds of the present invention of the formula are thyromimetic agents which can be used to prevent and/or treat diseases associated with an imbalance of thyroid hormones, such as hypo- and hyper-thyroidism, obesity, osteoporosis and depression. The compounds of the invention are, in particular, hypolipedemic agents which enhance the clearance of cholesterol from circulation, particularly the clearance of cholesterol in the form of low density lipoproteins (LDL). The compounds are useful for reducing total cholesterol plasma levels in mammals, in particular for reducing levels of LDL-cholesterol. Furthermore, such compounds also lower elevated lipoprotein (a) [Lp(a)] levels, an independent cardiovascular risk factor, in mammals.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: September 14, 2004
    Assignee: Novartis AG
    Inventor: Paivi Jaana Kukkola
  • Patent number: 6790979
    Abstract: The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in a subject afflicted with an androgen-related affliction. Examples of androgen-related afflictions include, but are not limited to, baldness, hirsutism, behavioral disorders, acne, and uninhibited spermatogenesis wherein inhibition of spermatogenesis is so desired.
    Type: Grant
    Filed: April 17, 2002
    Date of Patent: September 14, 2004
    Assignee: University of North Carolina at Chapel Hill
    Inventors: Kuo-Hsiung Lee, Junko Ishida, Hironari Ohtsu, Hui-Kang Wang, Hideji Itokawa, Chawnshang Chang, Charles C-Y. Shih
  • Patent number: 6790980
    Abstract: The present invention is directed to methods and compositions for treating upper respiratory indications, such as the treatment, management or mitigation of cough, cold, cold-like symtoms, symtoms related to upper respiratory infections, influenza symptoms and allergic rhinitis, perennial rhinitis, nasal and Eustachian tube congestion in an animal by administration of tannate compositions comprising single agent formulations or combinations of at least one or more agents into a single administrative dose.
    Type: Grant
    Filed: October 2, 2002
    Date of Patent: September 14, 2004
    Assignee: First Horizon Pharmaceutical Corporation
    Inventor: Balaji Venkataraman
  • Patent number: 6790981
    Abstract: The invention relates to a process for the preparation of acyloxybenzenesulfonates starting from carbonyl halides and salts of phenolsulfonic acid which have a low water content. Surprisingly, it was discovered that acyloxybenzenesulfonates can be prepared in high yields and good grades, irrespective of the grade or reactivity of the phenolsulfonic acid derivative, if the reaction of the phenolsulfonic acid with an alkanecarboxylic acid derivative is carried out in an aliphatic or aromatic solvent in the presence of 0.5 to 25% by weight of a polyglycol ether.
    Type: Grant
    Filed: December 13, 2002
    Date of Patent: September 14, 2004
    Assignee: Clariant Finance (BVI) Limited
    Inventors: Wolf-Dieter Mueller, Peter Naumann
  • Patent number: 6790982
    Abstract: The present invention provides a process whereby fluorine atom-containing sulfonyl fluoride compound(s) useful as e.g. materials for ion-exchange membranes, can be produced efficiently and at low cost without structural limitations while solving the difficulties in production. The present invention is also directed to a compound of the following formula (I) or a compound of the following formula (II): FSO2CH2CH2OCH2OCOCF(CF3)OCF2CF2CF3  (I) FSO2CF2CF2OCF2CF2OCOCF(CF3)OCF2CF2CF3  (II).
    Type: Grant
    Filed: May 21, 2003
    Date of Patent: September 14, 2004
    Assignee: Asahi Glass Company, Limited
    Inventors: Masahiro Ito, Kunio Watanabe, Takashi Okazoe, Isamu Kaneko, Daisuke Shirakawa
  • Patent number: 6790983
    Abstract: An integrated process for the production of vinyl acetate comprising the steps of: (a) containing in a first reaction zone a gaseous feedstock comprising essentially ethane with a molecular oxygen-containing gas in the presence of a catalyst to produce a first product stream comprising acetic acid and ethylene; (b) containing in a second reaction zone the first gaseous product stream with a molecular oxygen-containing gas in the presence of a catalyst to produce a second product stream comprising vinyl acetate; (c) separating the product stream from step (b) recovering vinyl acetate from the product stream from step (b).
    Type: Grant
    Filed: November 19, 2002
    Date of Patent: September 14, 2004
    Assignee: Celanese International Corporation
    Inventors: Sabine Zeyss, Uwe Dingerdissen, John Fritch
  • Patent number: 6790984
    Abstract: A process for purifying pravastatin sodium comprising the steps of: a. clarifying a fermentation broth containing pravastatin sodium to obtain a clear solution; and adjusting the clear solution to be basic having pH value ranging from pH 10˜13; b. adsorbing the pravastatin sodium with non-ionic resin; eluting the pravastatin sodium by water-soluble organic solvent; and forming a concentrate of pravastatin sodium; c. treating the concentrate with water-soluble anti-solvent or inorganic salt to form a precipitate of pravastatin sodium; and d. recrystallizing the precipitate for making pravastatin sodium crystal with high purity and high yield.
    Type: Grant
    Filed: May 14, 2003
    Date of Patent: September 14, 2004
    Assignee: Chunghwa Chemical Synthesis & Biotech Co., Ltd.
    Inventors: Jing-Chen Mai, Chiou-Jour Laih, Yu-Chin Chiang
  • Patent number: 6790985
    Abstract: Phosphonium salts represented by the general formula (I) wherein R1 and R2 each represents a phenyl group which may be substituted by a lower alkyl group, R3 represents a phenylene group which may be substituted by a lower alkyl group, R7 and R8 each represents a hydrogen atom or a hydrocarbon group having 1 to 12 carbon atoms which may be substituted and R9 represents a hydrogen atom or a hydrocarbon group having 1 to 5 carbon atoms which may be substituted; processes for producing the same and uses for the same; phosphines providing the same, and processes for producing said phosphines.
    Type: Grant
    Filed: April 1, 2002
    Date of Patent: September 14, 2004
    Assignee: Kuraray Co., Ltd.
    Inventors: Kazuyuki Yada, Kenji Shimoyamada, Masahiro Muranaka, Junichi Fuji, Shigeaki Suzuki
  • Patent number: 6790986
    Abstract: Gabapentin free from mineral acids anions is obtained by precipitating from a gabapentin aqueous solution a corresponding hydroxybenzoate, from which pure gabapentin is subsequently obtained by dissolution in a lower alcohol and treatment with a tertiary base.
    Type: Grant
    Filed: May 27, 2003
    Date of Patent: September 14, 2004
    Assignee: Farchemia S.r.l.
    Inventors: Gabriele Breviglieri, Sergio Contrini, Cinzia Assanelli
  • Patent number: 6790987
    Abstract: The present invention relates to a process of cleaving lactones optionally having functional groups to give carboxylic acids, where the corresponding lactone is reacted with hydrogen with catalysis by a compound of a metal of group VIII of the Periodic Table of the Elements which has been modified with organophosphines. The process is preferably carried out in a two-phase system using catalysts which have water-soluble phosphine ligands. The reaction is particularly suitable for cleavage 2-ethylidene-6-hepten-5-olide to give ethylidene-6-heptenecarboxylic acid or isomers thereof. This carboxylic acid can be hydrogenated in a manner known per se to give 2-ethylheptanoic acid.
    Type: Grant
    Filed: February 20, 2003
    Date of Patent: September 14, 2004
    Assignee: BASF Aktiengesellschaft
    Inventors: Arno Behr, Volker Brehme
  • Patent number: 6790988
    Abstract: A catalyst comprising a promoted mixed metal oxide is useful for the vapor phase oxidation of an alkane or a mixture of an alkane and an alkene to an unsaturated carboxylic acid and for the vapor phase ammoxidation of an alkane or a mixture of an alkane and an alkene to an unsaturated nitrile.
    Type: Grant
    Filed: May 7, 2003
    Date of Patent: September 14, 2004
    Assignee: Rohm and Haas Company
    Inventors: Sanjay Chaturvedi, Anne Mae Gaffney, Scott Han, Michele Doreen Heffner, Ruozhi Song
  • Patent number: 6790989
    Abstract: This invention is directed to novel oxamyl dipeptide ICE/ced-3 family inhibitor compounds having the following structure: wherein A, B, R, R1, R1′ p and q are as defined herein. The invention is also directed to pharmaceutical compositions containing one or more of these compounds, as well as to the use of such compositions in the treatment of patients suffering inflammatory, autoimmnune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.
    Type: Grant
    Filed: July 18, 2001
    Date of Patent: September 14, 2004
    Assignee: Idun Pharmaceuticals, Inc.
    Inventors: Robert J. Ternansky, Patricia L. Gladstone, Kevin J. Tomaselli, Bin Chao, Steven D. Linton
  • Patent number: 6790990
    Abstract: Disclosed is a method for the preparation of a fluorosulfonyl imide monomer of the structure represented by formula (IV), wherein X is F or perfluoroalkyl having 1-4 carbons optionally substituted by ether oxygen, M is an alkali or alkaline earth metal when y is respectively 1 or 2, R is aryl, fluoro-aryl, or XCF2-where X is H, halogen, fluorinated or non-fluorinated linear or cyclic alkyl having 1-10 carbons, optionally substituted by one or more ether oxygens. Such monomers are useful for forming ionomers useful in electrochemical applications such as batteries, fuel cells, electrolysis cells, ion exchange membranes, sensors, electrochemical capacitors, strong acid catalysts, and modified electrodes.
    Type: Grant
    Filed: June 14, 2002
    Date of Patent: September 14, 2004
    Assignee: E. I. du Pont de Nemours and Company
    Inventor: Hanne Anna Katherina Blau
  • Patent number: 6790991
    Abstract: A process for producing fomesafen from acifluorfen comprises the steps of (a) converting acifluorfen to its acid chloride, (b) coupling the acid chloride so formed with methanesulphonamide to form crude fomesafen and (c) purifying the crude fomesafen, characterized in that each of the steps is carried out in a single common solvent, which is preferably a chloroalkane. Preferably the steps are telescoped together so that there is no isolation of the product for any step until fomesafen is obtained.
    Type: Grant
    Filed: June 20, 2002
    Date of Patent: September 14, 2004
    Assignee: Syngenta Limited
    Inventors: Stephen Martin Brown, Brian David Gott, James Peter Muxworthy
  • Patent number: 6790992
    Abstract: The present invention relates to novel scyphostatin analogues, which distinguish themselves by acting as SMase inhibitors so that they are of therapeutic use for a number of diseases such as a HIV infection, neurodegenerative diseases, inflammatory diseases, apoplexy, ischemia, myocardial infarction or in the case of atherosclerosis.
    Type: Grant
    Filed: August 22, 2002
    Date of Patent: September 14, 2004
    Assignee: Biofrontera Pharmaceuticals GmbH
    Inventor: Hans-Peter Deigner
  • Patent number: 6790993
    Abstract: The present invention relates to new aromatic diamines. More particularly, the present invention relates to new aromatic diamines prepared from cashew nut shell liquid (CNSL), which is a renewable resource material. The present invention particularly relates to novel 1,1-bis(4-aminophenyl)-3-alkylcyclohexanes and to a method for their preparation.
    Type: Grant
    Filed: July 17, 2003
    Date of Patent: September 14, 2004
    Assignee: Council of Scientific and Industrial Research
    Inventors: Rahul Diliprao Shingte, Prakash Purushottam Wadgaonkar
  • Patent number: 6790994
    Abstract: The present invention relates to a process for the hydrogenation of nitrile functional groups to amine functional groups. It relates more particularly to a process for the complete or partial hydrogenation of dinitrile compounds to diamine or aminonitrile compounds. The invention relates to a process for the hydrogenation of nitrile functional groups to amine functional groups using hydrogen in the presence of a hydrogenation catalyst and of a strong inorganic base preferably deriving from an alkali metal or alkaline earth metal. According to the invention, the process comprises a stage of conditioning the catalyst which consists in mixing the hydrogenation catalyst, a predetermined amount of strong inorganic base and a solvent in which the strong inorganic base is not very soluble. This solvent is an amine compound, such as hexamethylenediamine in the case of the hydrogenation of adiponitrile to HMD and/or aminocapronitrile.
    Type: Grant
    Filed: January 10, 2003
    Date of Patent: September 14, 2004
    Assignee: Rhodia Polyamide Intermediates
    Inventors: Vincent Boschat, Philippe Leconte
  • Patent number: 6790995
    Abstract: Mixtures of primary amines of the formula (I) X—CH2—NH2  (I) and secondary amines of the formula (II) (X—CH2—)2NH  (II) where X is C1-20-alkyl, C2-20-alkenyl or C3-8-cycloalkyl which may be unsubstituted or substituted by C1-20-alkyl, C3-8-cycloalkyl, C4-20-alkylcycloalkyl, C4-20-cycloalkylalkyl, C2-20-alkoxyalkyl, C6-14-aryl, C7-20-alkylaryl, C7-20-aralkyl, C1-20-alkoxy, hydroxy, C1-20-hydroxyalkyl, amino, C1-20-alkylamino, C2-20-dialkylamino, C2-12-alkenylamino. C3-8-cycloalkylamino, arylamino, diarylamino, aryl-C1-8-alkylamino, halogen, mercapto, C2-20-alkenyloxy, C3-8-cycloalkoxy, aryloxy and/or C2-8-alkoxycarbonyl are prepared by reacting nitriles of the formula (III) X—CN  (III) with hydrogen at from 50 to 250° C. and pressures of from 5 to 350 bar in the presence of a Pd-containing catalyst comprising, based on the total weight of the catalyst, from 0.1 to 10% by weight of Pd on a support.
    Type: Grant
    Filed: January 3, 2002
    Date of Patent: September 14, 2004
    Assignee: BASF Aktiengesellschaft
    Inventors: Joachim Pfeffinger, Michael Hüllmann, Arthur Höhn, Frank Funke, Frank Ohlbach, Till Gerlach
  • Patent number: 6790996
    Abstract: The invention relates to a process for preparing primary amines by hydrogenating nitrites in the presence of a catalyst comprising cobalt and optionally, in addition, nickel and also at least one further doping metal on a particulate support material, the cobalt and, if present, the nickel having an average particle size of from 3 to 30 nm in the active catalyst. The invention further relates to the use of the catalyst in a process for preparing primary amines by hydrogenating nitrites.
    Type: Grant
    Filed: October 17, 2002
    Date of Patent: September 14, 2004
    Assignee: BASF Aktiengesellschaft
    Inventors: Andreas Ansmann, Christoph Benisch
  • Patent number: 6790997
    Abstract: The invention relates to a process for the preparation of carbonyl compounds by the oxidation of alcohols in the presence of osmium compounds as catalysts in water or a solvent mixture containing water.
    Type: Grant
    Filed: July 23, 2002
    Date of Patent: September 14, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Markus Eckert, Hans-Christian Militzer, Matthias Beller, Christian Döbler, Gerald Mehltretter, Uta Sundermeier
  • Patent number: 6790998
    Abstract: The invention relates to a process for the enantioselective preparation of tolterodine and analogues and salts thereof comprises the steps of: a) enantioselectively reducing the carbonyl function in a compound of formula (II): wherein R1, R2 and R3 independently of each other are hydrogen, methyl, methoxy, hydroxy, hydroxymethyl, carbamoyl, sulphamoyl or halogen, to form an enantiomerically enriched compound of formula (IIIa) or (IIIb): wherein R1, R2 and R3 are as defined above; b) subjecting the compound of formula (IIIa) or (IIIb) to a sigmatropic rearrangement to form a corresponding enantiomerically enriched compound of formula (IVa) or (IVb): wherein R1, R2 and R3 are as defined above; c) subjecting the compound of formula (IVa) or (IVb) to a Baeyer-Villiger oxidation to form a corresponding enantiomerically enriched compound of the general formula (Va) or (Vb).
    Type: Grant
    Filed: March 28, 2003
    Date of Patent: September 14, 2004
    Assignee: Pharmacia AB
    Inventors: Pher G. Andersson, Christian Hedberg
  • Patent number: 6790999
    Abstract: Disclosed is a process for the continuous, semi-continuous or batch production of 3-buten-1-ol from 3,4-epoxy-1-butene wherein 3,4-epoxy-1-butene and formic acid are fed to a reaction zone having a catalyst solution comprising a palladium(0) compound, a tertiary phosphine, a trialkylamine and an organic solvent. Preferably in the operation of this invention, 3-buten-1-ol product and reaction side products serve as the organic solvent for the process. The preferred mode of operation is continuous addition of reactants to the reaction mixture with simultaneous, continuous distillation of a reaction product comprising 3-buten-1-ol.
    Type: Grant
    Filed: February 28, 2003
    Date of Patent: September 14, 2004
    Assignee: Eastman Chemical Company
    Inventor: Stephen Neal Falling
  • Patent number: 6791000
    Abstract: Nitration of benzene is an important reaction for the production of nitro benzene, which is an important intermediate in chemical and pharmaceutical industries. Conventionally nitrobenzene is produced by liquid phase reactions employing mixed acids. A sulfuric acid/nitric acid mixture is the most commonly used nitrating agent. Generation of large amount dilute sulfuric acid, organic wastes and products of their neutralization makes the benzene nitration a environmentally harmful process. The present process enables the preparation of nitrobenzene by vapor phase nitration of benzene over solid acid catalyst, MoO3/SiO2 using nitric acid. This process is a clean and environment friendly process without use of sulphuric acid.
    Type: Grant
    Filed: May 30, 2003
    Date of Patent: September 14, 2004
    Assignee: Council of Scientific and Industrial Research
    Inventors: Mohan Keraba Dongare, Pratap Tukaram Patil, Kusum Madhukar Malshe
  • Patent number: 6791001
    Abstract: A process in gaseous phase to obtain CFC 113a starting from CFC 113, wherein CFC 113, optionally diluted with a gas inert under the reaction conditions, is let flow on a catalyst formed by aluminum fluoride.
    Type: Grant
    Filed: February 12, 2002
    Date of Patent: September 14, 2004
    Assignee: Ausimont S.p.A.
    Inventors: Paolo Cuzzato, Letanzio Bragante
  • Patent number: 6791002
    Abstract: A riser reactor system for conversion of hydrocarbon feedstock to ethylene and propylene is described. The riser reactor system prevents riser reactors with a plurality of inlet ports for feeding gases having different compositions and for controlling the residence time of a gas catalyst within the riser reactor.
    Type: Grant
    Filed: December 11, 2002
    Date of Patent: September 14, 2004
    Assignee: UOP LLC
    Inventors: Hayim Abrevaya, Joel T. Walenga, Michael A. Schultz, Anil R. Oroskar
  • Patent number: 6791003
    Abstract: A dual drug containing adhesive transdermal drug delivery system comprising: a support layer, a first drug containing adhesive layer and a second drug containing adhesive layer each of said layers having a proximal and distal surface wherein each layer is positioned adjacent to the other with each layer having its distal surface laminated to said support layer, and a peelable backing layer positioned over and laminated to the proximal surface of said first and second adhesive layers is disclosed.
    Type: Grant
    Filed: August 9, 2002
    Date of Patent: September 14, 2004
    Assignee: Samyang Corporation
    Inventors: Young Kweon Choi, Hyun Suk Yu, Hye Jeong Yoon, Ho Chin Kim
  • Patent number: 6791004
    Abstract: An absorbent article which includes a thermal cell actuator capable of adding or removing heat to or from at least a portion of the absorbent article to perform a useful function on the article. The thermal cell actuator may be activated by an action of the wearer or caregiver or by environmental conditions between the article and wearer.
    Type: Grant
    Filed: February 7, 2001
    Date of Patent: September 14, 2004
    Assignee: The Procter & Gamble Company
    Inventors: Cornelia Sprengard-Eichel, Mark James Kline, Bruno Johannes Ehrnsperger, Tracey Elaine Beckman, Constance Lee Fisher, Mattias Schmidt, Donald Carroll Roe, Bruce Ernest Tepper
  • Patent number: 6791005
    Abstract: An absorbent article, such as a sanitary napkin, a panty liner or a female incontinence napkin, is intended to be carried in the crotch part of the wearer inside her underwear, has a generally elongate shape and includes two long sides, two short sides, two end-portions, a center portion located between the end-portions, a liquid-permeable casing sheet that is intended to lie proximal to the wearer's body in use, a liquid-impermeable casing sheet that is intended to lie distal form the wearer's body in use, and further includes between the layers, as seen in a direction from the liquid-permeable casing sheet towards the liquid-impermeable casing sheet, a drainage layer, an absorption layer, and a hump-forming element which forms together with the drainage layer and the absorption layer a hump that projects out from the plane of the napkin on that side of the napkin which is intended to lie proximal to the wearer in the use.
    Type: Grant
    Filed: December 6, 2001
    Date of Patent: September 14, 2004
    Assignee: SCA Hygiene Products AB
    Inventors: Eje Österdahl, Åsa Johansson, Ulrika Husmark, Ingrid Gustafson, Anna Stoltze
  • Patent number: 6791006
    Abstract: A mammal is provided, in which the LKB1 gene can be deleted phase-specifically and tissue-specifically. These mammals are highly useful as tools to reveal the onset mechanism for diseases caused by LKB1 gene deficiency, such as Peutz-Jeghers syndrome and cancers, as well as to develop therapeutic agents, methods, and so on for the diseases.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: September 14, 2004
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Jun-Ichi Nezu, Asuka Ose, Kou-Ichi Jishage, Dieter E. Jenne
  • Patent number: 6791007
    Abstract: The present invention relates to stimulating a defense response in plants, with a view to providing the plants with enhance pathogen resistance.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: September 14, 2004
    Assignees: Plant Bioscience Limited, Keygene N.V.
    Inventors: Paul M. J. Schulze-Lefert, Ralph Panstruga, Rainer Büschges, Augustinus F. M. Simons, Johannes S. Groenendijk, Theodoor A. J. Van Der Lee
  • Patent number: 6791008
    Abstract: The present invention relates to the use of a novel enzyme and its encoding gene for transformation. More specifically, the invention relates to the use of a gene encoding an enzyme with acyl-CoA:diacylglycerol acyltransferase activity. This gene expressed alone in transgenic organisms will increase the total amount of oil (i.e. triacylglycerols) that is produced.
    Type: Grant
    Filed: November 13, 2000
    Date of Patent: September 14, 2004
    Assignee: Scandinavian Biotechnology Research (ScanBi) AB
    Inventors: Antoni Banas, Line Sandager, Ulf Ståhl, Anders Dahlqvist, Marit Lenman, Hans Ronne, Sten Stymne
  • Patent number: 6791009
    Abstract: The present invention relates to novel nucleic acid construct comprising (a) an anti-sense gene of a sense gene encoding E. histolytica calcium binding protein or a portion of said anti-sense gene, wherein said sense gene is at least 90% similar to the nucleic sequence of SEQ ID No: 1, and wherein said portion of the anti-sense gene is of a size capable of disrupting translation of said calcium binding protein; and (b) a constitutive promoter and a nopaline synthase (nos) polyadenylation signal sequence both operatively linked to said gene or portion thereof; wherein said construct is useful for increasing the level of chlorophyll in plants, a transgenic plant containing said construct and a novel nucleic acid construct useful for developing stress-tolerant plants, comprising (a) a sense gene encoding E.
    Type: Grant
    Filed: February 14, 2000
    Date of Patent: September 14, 2004
    Assignee: Council of Scientific and Industrial Research
    Inventors: Girdhar Kumar Pandey, Vanga Siva Reddy, Renu Deswal, Alok Bhattacharya, Sudhir Kumar Sopory
  • Patent number: 6791010
    Abstract: The present invention relates to nucleic acid molecules coding for a protein with beta-amylase activity from potato and to a method for the production of transgenic plant cells and plants synthesizing a modified starch. The invention also relates to vectors and host cells containing the nucleic acid molecules according to the invention, the plant cells and plants produced using the method according to the invention and the starch synthesized by the plant cells and plants according to the invention. The invention also relates to a method of production of said starch.
    Type: Grant
    Filed: May 31, 2001
    Date of Patent: September 14, 2004
    Assignee: Bayer CropScience GmbH
    Inventor: Claus Frohberg
  • Patent number: 6791011
    Abstract: The invention relates to pairs of parent plants for producing hybrid seeds and to methods for producing plants with a desired phenotype. The desired phenotype is an active enzyme, a regulatory protein or a protein which affects the functionality and/or viability and/or structural integrity of a cell. Preferably, the desired phenotype is substantially absent from the parent plants/lines. In particular, the invention relates to parent plants and methods involving plant lines for producing male-sterile plants and seeds.
    Type: Grant
    Filed: August 20, 1999
    Date of Patent: September 14, 2004
    Assignee: Gene Shears Pty. Limited
    Inventors: Wyatt Paul, Pascual Perez, Eric Huttner, Andreas Stefan Betzner
  • Patent number: 6791012
    Abstract: A transgenic turfgrass plant expressing a betaine aldehyde dehydrogenase-encoding transgene is provided. The transgenic plant displays significantly increased tolerance to salinity than does its non-transgenic equivalents. The plant also displays increased tolerance to drought conditions. The salt- and drought-tolerant transgenic turfgrass may be planted in regions of high salinity, such as seaside, or in regions where irrigation water is scarce.
    Type: Grant
    Filed: March 27, 2001
    Date of Patent: September 14, 2004
    Assignee: Rutgers The State University of New Jersey
    Inventors: Tseh An Chen, Shou-Yi Chen, Gen-Yun Zhang, Faith C. Belanger
  • Patent number: 6791013
    Abstract: The maize myo-inositol-1-phosphate synthase (MIP synthase) promoter is a novel embryo specific regulatory sequence useful in expressing heterologous nucleic acids in plants.
    Type: Grant
    Filed: December 1, 2000
    Date of Patent: September 14, 2004
    Assignee: Dow AgroSciences LLC
    Inventors: Katherine Armstrong, Timothy D. Hey, Otto Folkerts, Kelley A. Smith, Nicole L. Hopkins
  • Patent number: 6791014
    Abstract: The present invention provides a method for transforming plants cells by introducing a heterologous gene into competent plant cells with a gene for tolerance to HPPD inhibitors as a selection marker wherein a step for bleaching the competent plant cells is carried out prior to transforming the cells by introducing a suitable amount of HPPD inhibitor into the cell culture medium. The invention also provides methods for preparing transgenic plants comprising a heterologous gene.
    Type: Grant
    Filed: August 2, 2001
    Date of Patent: September 14, 2004
    Assignee: Aventis Cropscience, S.A.
    Inventors: Frédéric Garcon, Bernard Pelissier
  • Patent number: 6791015
    Abstract: This invention relates to isolated nucleic acid fragments encoding fructosyltransferases. More specifically, this invention relates to polynucleotides encoding 1-FFTs, 6-SFTs, or 1-SSTs. The invention also relates to the construction of a recombinant DNA constructs encoding all or a portion of the fructosyltransferases, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels of the fructosyltransferases in a transformed host cell.
    Type: Grant
    Filed: October 30, 2001
    Date of Patent: September 14, 2004
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: Stephen M. Allen, Perry G. Caimi, Johan M. Stoop
  • Patent number: 6791016
    Abstract: According to the invention, there is provided a novel soybean variety, designated 93M40. This invention thus relates to the seeds of soybean variety 93M40, to the plants of soybean 93M40 to plant parts of soybean variety 93M40 and to methods for producing a soybean plant produced by crossing soybean variety 93M40 with another soybean plant, using 93M40 as either the male or the female parent. This invention also relates to methods for producing a soybean plant containing in its genetic material one or more transgenes and to the transgenic soybean plants and plant parts produced by those methods. This invention also relates to soybean varieties or breeding varieties and plant parts derived from soybean variety 93M40, to methods for producing other soybean varieties, lines or plant parts derived from soybean variety 93M40 and to the soybean plants, varieties, and their parts derived from use of those methods.
    Type: Grant
    Filed: January 31, 2003
    Date of Patent: September 14, 2004
    Assignee: Pioneer Hi-Bred International, Inc.
    Inventors: Debra Kay Steiger, Herbert J. Schmidt
  • Patent number: 6791017
    Abstract: Methods of making guitar pick holders from flexible magnetic materials are described. In one illustrative example, a magnetic side of a flexible magnetic sheet is laminated with a vinyl sheet which provides a coloring and/or design. The side opposite this magnetic side is laminated with a static cling vinyl sheet, after text is reverse-printed on its non-static cling side. Coloring, design, and/or text may also be printed on the vinyl sheet. The laminated flexible magnetic sheet is then die cut to simultaneously form a plurality of guitar pick holders of a predetermined shape. Other methods are described, including methods of individually making custom guitar pick holders.
    Type: Grant
    Filed: February 13, 2003
    Date of Patent: September 14, 2004
    Inventor: John Jeffrey Oskorep